Healthcare Services

Losartan Market Developments and Opportunities Through 2030

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Losartan Market In 2026 And 2030?

The losartan market size has demonstrated consistent expansion in recent years. It is anticipated to increase from $1.49 billion in 2025 to $1.55 billion in 2026, progressing at a compound annual growth rate (CAGR) of 4.2%. Historically, this growth was primarily driven by factors such as the escalating global burden of hypertension, the widespread clinical adoption of ARBs, a rising incidence of diabetes-related kidney disease, improved awareness of cardiovascular risk management, and an early shift from ACE inhibitors to ARBs.

The losartan market is projected to experience consistent expansion over the upcoming years. This market is predicted to reach $1.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. Factors driving this expansion during the forecast period include an aging global populace, an increasing need for kidney-protecting antihypertensive medications, broader availability of cost-effective generic drugs, a heightened emphasis on preventing strokes, and greater healthcare expenditure directed towards managing chronic illnesses. Key trends anticipated during the same period encompass the growing incidence of hypertension and cardiovascular conditions, a developing preference for ARBs over ACE inhibitors, an increase in prescriptions for generic losartan, its expanding application in the management of diabetic nephropathy, and a surge in the adoption of long-term blood pressure control therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Key Factors Are Driving The Losartan Market Growth?

The increasing prevalence of hypertension is expected to propel the growth of the losartan market going forward. Hypertension is a condition characterized by persistently elevated blood pressure, which can increase the likelihood of heart disease, stroke, and other severe health complications. The rising incidence of hypertension is linked to diets rich in salt and processed foods, which lead to fluid retention and increased strain on the heart. Losartan helps control hypertension by blocking angiotensin II, a hormone that narrows blood vessels. This action aids in relaxing and widening the vessels, consequently lowering blood pressure and easing the heart’s workload. For instance, in January 2025, according to the Centers for Disease Control and Prevention, a US-based organisation, in 2023, high blood pressure played a primary or contributing role in 664,470 deaths in the United States. Therefore, the growing prevalence of hypertension is driving the growth of the losartan market.

How Are Segments Identified Within The Losartan Market Segment Framework?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

Which Trends Are Guiding The Direction Of The Losartan Market?

Major companies operating in the losartan market are concentrating on developing innovative products and securing approvals, such as losartan potassium oral suspension, to improve patient compliance and expand therapeutic applications. Losartan potassium oral suspension is a liquid form of medication losartan potassium, intended for individuals who experience difficulty swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) clearance for Arbli. It is a ready-to-use liquid formulation designed for hypertension, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. Arbli offers precise dosing without compounding and is available as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

Who Are The Companies Competing Within The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Get The Full Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Which Region Leads The Losartan Market In Overall Market Size?

North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Losartan Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Browse Through More Reports Similar to the Global Losartan Market 2026, By The Business Research Company

Lysine Market Report 2026

https://www.thebusinessresearchcompany.com/report/lysine-global-market-report

Caviar Market Report

https://www.thebusinessresearchcompany.com/report/caviar-global-market-report

Liraglutide Market Report

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795